Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPITIC
NCT03441412Phase 1Completed
- Sponsor
- Region Västra Götaland
- Start
- Feb 2018
- Primary completion
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of epinephrine in hemorrhage, sponsored by Region Västra Götaland. Primary endpoint: Area under the aggregation curve (AUC) for adenosine diphosphate (ADP)-induced platelet aggregation at 4 hours. Started Feb 2018; status: completed.
02
Drugs
epinephrine
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT03441412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03441412.